201 related articles for article (PubMed ID: 31080012)
1. Structure of the DNA-Bound Spacer Capture Complex of a Type II CRISPR-Cas System.
Wilkinson M; Drabavicius G; Silanskas A; Gasiunas G; Siksnys V; Wigley DB
Mol Cell; 2019 Jul; 75(1):90-101.e5. PubMed ID: 31080012
[TBL] [Abstract][Full Text] [Related]
2. DnaQ exonuclease-like domain of Cas2 promotes spacer integration in a type I-E CRISPR-Cas system.
Drabavicius G; Sinkunas T; Silanskas A; Gasiunas G; Venclovas Č; Siksnys V
EMBO Rep; 2018 Jul; 19(7):. PubMed ID: 29891635
[TBL] [Abstract][Full Text] [Related]
3. How type II CRISPR-Cas establish immunity through Cas1-Cas2-mediated spacer integration.
Xiao Y; Ng S; Nam KH; Ke A
Nature; 2017 Oct; 550(7674):137-141. PubMed ID: 28869593
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the anti-CRISPR, AcrIIC4.
Kim GE; Lee SY; Park HH
Protein Sci; 2021 Dec; 30(12):2474-2481. PubMed ID: 34676610
[TBL] [Abstract][Full Text] [Related]
5. Cas3-Derived Target DNA Degradation Fragments Fuel Primed CRISPR Adaptation.
Künne T; Kieper SN; Bannenberg JW; Vogel AI; Miellet WR; Klein M; Depken M; Suarez-Diez M; Brouns SJ
Mol Cell; 2016 Sep; 63(5):852-64. PubMed ID: 27546790
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for self-cleavage prevention by tag:anti-tag pairing complementarity in type VI Cas13 CRISPR systems.
Wang B; Zhang T; Yin J; Yu Y; Xu W; Ding J; Patel DJ; Yang H
Mol Cell; 2021 Mar; 81(5):1100-1115.e5. PubMed ID: 33472057
[TBL] [Abstract][Full Text] [Related]
7. Probing the Behaviour of Cas1-Cas2 upon Protospacer Binding in CRISPR-Cas Systems using Molecular Dynamics Simulations.
Wan H; Li J; Chang S; Lin S; Tian Y; Tian X; Wang M; Hu J
Sci Rep; 2019 Feb; 9(1):3188. PubMed ID: 30816277
[TBL] [Abstract][Full Text] [Related]
8. CRISPR DNA elements controlling site-specific spacer integration and proper repeat length by a Type II CRISPR-Cas system.
Kim JG; Garrett S; Wei Y; Graveley BR; Terns MP
Nucleic Acids Res; 2019 Sep; 47(16):8632-8648. PubMed ID: 31392984
[TBL] [Abstract][Full Text] [Related]
9. Cas4-Dependent Prespacer Processing Ensures High-Fidelity Programming of CRISPR Arrays.
Lee H; Zhou Y; Taylor DW; Sashital DG
Mol Cell; 2018 Apr; 70(1):48-59.e5. PubMed ID: 29602742
[TBL] [Abstract][Full Text] [Related]
10. DNA Targeting by a Minimal CRISPR RNA-Guided Cascade.
Hochstrasser ML; Taylor DW; Kornfeld JE; Nogales E; Doudna JA
Mol Cell; 2016 Sep; 63(5):840-51. PubMed ID: 27588603
[TBL] [Abstract][Full Text] [Related]
11. Cas1 and Cas2 From the Type II-C CRISPR-Cas System of
He Y; Wang M; Liu M; Huang L; Liu C; Zhang X; Yi H; Cheng A; Zhu D; Yang Q; Wu Y; Zhao X; Chen S; Jia R; Zhang S; Liu Y; Yu Y; Zhang L
Front Cell Infect Microbiol; 2018; 8():195. PubMed ID: 29951376
[TBL] [Abstract][Full Text] [Related]
12. Direct observation of DNA target searching and cleavage by CRISPR-Cas12a.
Jeon Y; Choi YH; Jang Y; Yu J; Goo J; Lee G; Jeong YK; Lee SH; Kim IS; Kim JS; Jeong C; Lee S; Bae S
Nat Commun; 2018 Jul; 9(1):2777. PubMed ID: 30018371
[TBL] [Abstract][Full Text] [Related]
13. Cas9 function and host genome sampling in Type II-A CRISPR-Cas adaptation.
Wei Y; Terns RM; Terns MP
Genes Dev; 2015 Feb; 29(4):356-61. PubMed ID: 25691466
[TBL] [Abstract][Full Text] [Related]
14. Cas9 Allosteric Inhibition by the Anti-CRISPR Protein AcrIIA6.
Fuchsbauer O; Swuec P; Zimberger C; Amigues B; Levesque S; Agudelo D; Duringer A; Chaves-Sanjuan A; Spinelli S; Rousseau GM; Velimirovic M; Bolognesi M; Roussel A; Cambillau C; Moineau S; Doyon Y; Goulet A
Mol Cell; 2019 Dec; 76(6):922-937.e7. PubMed ID: 31604602
[TBL] [Abstract][Full Text] [Related]
15. Bacteriophage Twort protein Gp168 is a β-clamp inhibitor by occupying the DNA sliding channel.
Liu B; Li S; Liu Y; Chen H; Hu Z; Wang Z; Zhao Y; Zhang L; Ma B; Wang H; Matthews S; Wang Y; Zhang K
Nucleic Acids Res; 2021 Nov; 49(19):11367-11378. PubMed ID: 34614154
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of Cas1 in complex with branched DNA.
Yang J; Li J; Wang J; Sheng G; Wang M; Zhao H; Yang Y; Wang Y
Sci China Life Sci; 2020 Apr; 63(4):516-528. PubMed ID: 31792780
[TBL] [Abstract][Full Text] [Related]
17. Dual nuclease activity of a Cas2 protein in CRISPR-Cas subtype I-B of Leptospira interrogans.
Dixit B; Ghosh KK; Fernandes G; Kumar P; Gogoi P; Kumar M
FEBS Lett; 2016 Apr; 590(7):1002-16. PubMed ID: 26950513
[TBL] [Abstract][Full Text] [Related]
18. Casposase structure and the mechanistic link between DNA transposition and spacer acquisition by CRISPR-Cas.
Hickman AB; Kailasan S; Genzor P; Haase AD; Dyda F
Elife; 2020 Jan; 9():. PubMed ID: 31913120
[TBL] [Abstract][Full Text] [Related]
19. CRISPR type II-A subgroups exhibit phylogenetically distinct mechanisms for prespacer insertion.
Van Orden MJ; Newsom S; Rajan R
J Biol Chem; 2020 Aug; 295(32):10956-10968. PubMed ID: 32513871
[TBL] [Abstract][Full Text] [Related]
20. Integrase-mediated spacer acquisition during CRISPR-Cas adaptive immunity.
Nuñez JK; Lee AS; Engelman A; Doudna JA
Nature; 2015 Mar; 519(7542):193-8. PubMed ID: 25707795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
